Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) EPS (Weighted Average and Diluted) (2010 - 2026)

Nephros' quarterly EPS (Weighted Average and Diluted) came in at $0.01 in Q1 2026, down 80.0% year-on-year from $0.05 in Q1 2025, and little changed quarter-over-quarter from $0.01 in Q4 2025.

Nephros has reported EPS (Weighted Average and Diluted) for 10 years, with the latest figure at $0.01 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 80.0% year-over-year to $0.01; the trailing twelve-month figure through Mar 2026 stood at $0.07 (down 12.5% YoY), and the FY2025 full-year result was $0.11, up 1000.0% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.01, roughly flat from $0.01 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.21 in Q4 2022, with the low at -$0.31 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.01, with a median of -$0.01 recorded in 2023.
  • Year-over-year, EPS (Weighted Average and Diluted) tumbled 128.57% in 2023 and jumped 350.0% in 2025.
  • Tracing NEPH's EPS (Weighted Average and Diluted) over 5 years: stood at $0.21 in 2022, then plunged by 128.57% to -$0.06 in 2023, then jumped by 166.67% to $0.04 in 2024, then slumped by 75.0% to $0.01 in 2025, then increased by 0.0% to $0.01 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at $0.01 (Q1 2026), $0.01 (Q4 2025), and $0.03 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.28
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -1.11
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 2.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.92
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.07
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.66
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.57
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -0.03
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.12
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn 0.01

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.03
Jun 30, 2025 0.02
Mar 31, 2025 0.05
Dec 31, 2024 0.04
Sep 30, 2024 0.02
Jun 30, 2024 -0.03
Mar 31, 2024 -0.02
Dec 31, 2023 -0.06
Sep 30, 2023 -0.02
Jun 30, 2023 -0.04
Mar 31, 2023 -0.03
Dec 31, 2022 0.21
Sep 30, 2022 -0.31
Jun 30, 2022 -0.12
Mar 31, 2016 -0.02
Sep 30, 2015 -0.02
Jun 30, 2015 -0.06
Mar 31, 2015 -0.02
Dec 31, 2014 -0.04
Sep 30, 2014 -0.02
Jun 30, 2014 -0.03
Mar 31, 2014 -0.19
Dec 31, 2013 -0.06
Jun 30, 2013 -0.03
Mar 31, 2013 -0.07
Dec 31, 2010 -0.29